BIND Therapeutics, Inc 4
4 · BIND Therapeutics, Inc · Filed Dec 16, 2015
Insider Transaction Report
Form 4
YINGLING JONATHAN MICHAEL
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2015-12-14+200,000→ 200,000 totalExercise: $2.38Exp: 2025-12-13→ COMMON STOCK (200,000 underlying)
Footnotes (1)
- [F1]Beginning on December 14, 2015, the option vests 25% after one year and in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.